BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17657269)

  • 1. [Comparison and analysis of different dendritic cell-based immunotherapeutic strategies for Ewing sarcoma: in vitro and in vivo induction on SCID mouse models].
    Zhao H; Tang S; Qu HY; Guo W; Li X; Peng CL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 39(4):403-8. PubMed ID: 17657269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell-Ewing's sarcoma cell hybrids enhance antitumor immunity.
    Guo W; Guo Y; Tang S; Qu H; Zhao H
    Clin Orthop Relat Res; 2008 Sep; 466(9):2176-83. PubMed ID: 18563501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells.
    Pinho MP; Sundarasetty BS; Bergami-Santos PC; Steponavicius-Cruz K; Ferreira AK; Stripecke R; Barbuto JA
    Cytotherapy; 2016 Apr; 18(4):570-80. PubMed ID: 26971685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy.
    Shimizu K; Kuriyama H; Kjaergaard J; Lee W; Tanaka H; Shu S
    J Immunother; 2004; 27(4):265-72. PubMed ID: 15235387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model.
    Peng W; Huang X; Yang D
    Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction of recombinant adenoviral vector containing gene of EWS-FLI1 and antitumor immunity of its modified dentritic cell in vitro].
    Qu HY; Guo W; He XJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 38(6):623-7. PubMed ID: 17173084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination.
    Wei FQ; Sun W; Wong TS; Gao W; Wen YH; Wei JW; Wei Y; Wen WP
    J Exp Clin Cancer Res; 2016 Jan; 35():18. PubMed ID: 26795730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer.
    Wang HL; Xu H; Lu WH; Zhu L; Yu YH; Hong FZ
    Arch Gynecol Obstet; 2014 Jan; 289(1):155-62. PubMed ID: 23912529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas: in vitro induction of cytolytic and natural killer-like T cells.
    Parajuli P; Mathupala S; Sloan AE
    Neurosurgery; 2004 Nov; 55(5):1194-204. PubMed ID: 15509326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro antitumor immune response induced by fusion of dendritic cells and Ewing's sarcoma cells].
    Tang S; Guo W; Guo Y; Qu HY; Li DS
    Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(12):803-6. PubMed ID: 16083585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
    Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
    Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
    Gao J; Chen M; Peng ML; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.
    Li X; Zhang Z; Lin G; Gao Y; Yan Z; Yin H; Sun B; Wang F; Zhang H; Chen H; Cao D
    Tumour Biol; 2016 Aug; 37(8):11267-78. PubMed ID: 26951511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
    Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
    Ackermann B; Tröger A; Glouchkova L; Körholz D; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(3):176-82. PubMed ID: 15175963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunotherapy strategies for Ewing sarcoma.
    Rossig C
    Immunotherapy; 2014; 6(5):611-21. PubMed ID: 24896629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapeutic reactivity of dendritic cells loaded with a variety of antigen preparations].
    Shimizu K; Kuriyama H; Tamai H; Ueda Y; Yamagishi H; Shu S
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1637-9. PubMed ID: 15553668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.